| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 201 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 201 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 201 |
| 3 | METHOTREXATE SODIUM | 193 |
| 4 | DEXAMETHASONE | 166 |
| 5 | DEXAMETHASONE 1.5 MG | 166 |
| 6 | RUXOLITINIB | 164 |
| 7 | LENALIDOMIDE | 162 |
| 8 | METHOTREXATE | 156 |
| 9 | DOXORUBICIN | 150 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TROPICAMIDE | 13 | 0.0080 |
| 1 | DASATINIB | 70 | 0.0075 |
| 2 | ROMIPLOSTIM | 54 | 0.0036 |
| 3 | ERGOCALCIFEROL | 98 | 0.0033 |
| 4 | DEFERASIROX | 77 | 0.0029 |
| 5 | PEGFILGRASTIM | 33 | 0.0028 |
| 6 | RUXOLITINIB | 164 | 0.0022 |
| 7 | VENETOCLAX | 140 | 0.0022 |
| 8 | METHADONE HYDROCHLORIDE | 24 | 0.0022 |
| 9 | STANDARDIZED SENNA CONCENTRATE | 25 | 0.0020 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 384 |
| 1 | Kinase Inhibitor [EPC] | 312 |
| 2 | Alkylating Drug [EPC] | 221 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 204 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 204 |
| 5 | Thalidomide Analog [EPC] | 192 |
| 6 | Janus Kinase Inhibitor [EPC] | 182 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 166 |
| 8 | Platinum-based Drug [EPC] | 160 |
| 9 | BCL-2 Inhibitor [EPC] | 140 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 24 | 0.0041 |
| 1 | CD22-directed Immunoconjugate [EPC] | 11 | 0.0037 |
| 2 | Thrombopoietin Receptor Agonist [EPC] | 54 | 0.0036 |
| 3 | Interferon gamma [EPC] | 5 | 0.0035 |
| 4 | Provitamin D2 Compound [EPC] | 98 | 0.0033 |
| 5 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 6 | Iron Chelator [EPC] | 78 | 0.0027 |
| 7 | Guanylate Cyclase-C Agonist [EPC] | 5 | 0.0024 |
| 8 | BCL-2 Inhibitor [EPC] | 140 | 0.0022 |
| 9 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 7 | 0.0021 |